EOS imaging (Euronext, FR0011191766 – EOSI) (Paris:EOSI), the pioneer in 2D/3D orthopedic medical imaging and associated solutions, today announced that Marie Meynadier, Chief Executive Officer, is scheduled to present at the 28th Annual Piper Jaffray Healthcare Conference in New York, NY.
|28th Annual Piper Jaffray Healthcare Conference|
|Wednesday November 30, 2016|
|3:30 pm ET / 9:30 pm CET|
A live webcast of the presentation will be available on EOS imaging’s website at www.eos-imaging.com. A replay of the webcast will be available for 30 days after the date of the presentation.
EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
About EOS imaging
EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States, Japan, China, and the European Union. The Group posted 2015 revenues of €21.8 million and employs 122 people. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161114005179/en/Business Wire
Last updated on: 14/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.